Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 202 shares at $112.51 ($23K) on 2019-03-13, disclosed to the SEC on 2019-03-15.
Open-market purchase of $23k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |